The Drug Enforcement Administration (DEA) has published a final rule to implement the Secure and Responsible Drug Disposal Act of 2010, which was intended to mitigate prescription drug abuse by providing safe and secure mechanisms for "ultimate users" to dispose of unused or unwanted pharmaceutical controlled substances.

Whistleblowers filed 638 qui tam suits in FY 2015, and whistleblower awards totaled $597 million.

The U.S. Department of Justice has announced a record $5.69 billion in civil False Claims Act settlements and judgments for FY 2014, including almost $3 billion in recoveries related to qui tam lawsuits.

The HHS Office for Human Research Protections published a notice announcing that it is seeking comments on draft guidance for the research community.

The FDA’s Office of Prescription Drug Promotion has warned a Swiss drug company about statements the company made on its Facebook page.

The House Energy & Commerce Committee has voted to approve H.R. 4725, Common Sense Savings Act of 2016, which includes a number of Medicaid and Children's Health Insurance Program (CHIP) reforms.

On July 29, 2015, the House Energy & Commerce Committee approved the following bipartisan bills that aim to improve health care for newborns, infants, and children

As mentioned on our Health Industry Washington Watch blog, the FDA will host a public workshop on April 1, 2015 to provide updates on the use of clinical outcome assessments (COAs)...

On January 16, 2014, the Food and Drug Administration (FDA) issued a final guidance document for industry providing specific recommendations on the content and format of Dear Health Care Provider (DHCP or "Dear Doctor") letters.

On March 2, 2016, the FDA is hosting a public workshop on "Patient and Medical Professional Perspectives on the Return of Genetic Test Results."

The FDA’s new "Purple Book" lists biological products licensed by FDA under the Public Health Service Act (the PHS Act).

CMS has posted the 2014 Medicare clinical lab fee schedule, including the 2014 national limit amounts for new molecular pathology codes.

CMS is expected to publish several major final Medicare payment rules for 2015 in the coming days.

On February 6, 2014, the Department of Health & Human Services published a final rule making changes to the Clinical Laboratory Improvement Amendments of 1988 and Health Insurance Portability and Accountability Act of 1996.

Finance Committee members are asking stakeholders for ideas on ways to improve the availability and utility of health care data, while protecting patient privacy.

The report also highlights major OIG audits of HHS programs, including reports covering quality of care, Medicare Part D spending, the hospital two midnight rule policy, and other Medicare and...

The Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) includes payment incentives to encourage providers to participate in alternative payment models (APMs) that focus on coordinating care, improving quality, and reducing costs.

On June 10, 2014, the full House Energy and Commerce Committee approved by voice vote three bipartisan public health bills.

The Government Accountability Office has issued a report examining the extent to which CMS's enrollment screening procedures are designed and implemented to prevent enrollment of ineligible or potentially fraudulent Medicare providers.

The GAO has released data comparing retail prescription drug prices paid by the DOD, Medicaid, and Medicare Part D for a sample of 78 high-utilization drugs.